Mirador Therapeutics

Series-B+
miradortx.com Biotech & Healthcare San Diego, United States Founded 2024 11-50
Total Funding $650M
Latest Round $250M Series-B+
Last Announced Jan 13, 2026
Investors 17 Backers
Decision Makers 6 Verified

About Mirador Therapeutics

Mirador Therapeutics develops precision medicines for immune-mediated inflammatory and fibrotic diseases. The company uses its Mirador360 engine, which combines biology, multi-modal data, AI, and analytics, to identify targets and select therapies. Mirador Therapeutics aims to discover and develop precision medicines for patients with immuno-fibrotic diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters San Diego, United States
Year Founded 2024
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website miradortx.com
Domain Registered Date Aug 8, 2023

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $250,000,000 · Series-B+

    Pulse 2.0

  2. Capital Raise

    Raised $400,000,000 · Series-A

  3. Milestone

    Company founded

    San Diego, United States

  4. Milestone

    Website domain registered

    miradortx.com

Investors & Backers

17
Adage Capital Management
Alexandria Venture Investments
ARCH Venture Partners
Fairmount
Farallon Capital Management
Fidelity
Fidelity Management & Research Company
Invus
Logos Capital
OrbiMed
Point72
Point72 Ventures
RTW Investments
Sanofi Ventures
T. Rowe Price
TCG Crossover
Woodline Partners

Funding History

2 Rounds
Series-B+ · Jan 13, 2026
$250,000,000 Pulse 2.0
Series-A · Mar 21, 2024
$400,000,000 Source

Founders & Leadership

9

Allison Luo

Chief Medical Officer

Work email & phone locked Unlock →

Gregg Gilbert

CFO

Work email & phone locked Unlock →

Jordan Zwick

Chief Business Officer

Work email & phone locked Unlock →

Mark McKenna

Founder

Work email & phone locked Unlock →

Maulik Shah

Chief Financial Officer

Work email & phone locked Unlock →

Nori Ebersole

Chief People Officer

Work email & phone locked Unlock →

Olivier Laurent

Chief Scientific Officer

Work email & phone locked Unlock →

Tim Andrews

Chief Legal Officer

Work email & phone locked Unlock →

William Sandborn

Chief Strategy Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts